Automation index

How much of a Investment analyst’s job can AI already do?

A model comes earlier. Calling buy or not and signing the memo do not.

This percentage does not predict how many people will lose their jobs.

Task comparison

IS WORK OVER?

27%

AI can already do 27% of this job.

#131 / 643

Investment analyst

Task weights are our estimates based on O*NET frequency data, not time shares published by O*NET.

The time saving for each task is estimated separately.

Task	Share	AI	Points
Model, comps and the memo. Estimate No public source provides a precise figure. This is our estimate.	18%	48%	+8.6
Data, the gap and what is not in the sheet. Estimate No public source provides a precise figure. This is our estimate.	16%	40%	+6.4
Committee, the thesis and the one who falls in love. Estimate No public source provides a precise figure. This is our estimate.	16%	22%	+3.5
Follow-up, the profit warning and not hiding it. Estimate No public source provides a precise figure. This is our estimate.	16%	28%	+4.5
The PM, the rush and not inflating the target. Estimate No public source provides a precise figure. This is our estimate.	18%	14%	+2.5
Buy or not, and signing the memo. Estimate No public source provides a precise figure. This is our estimate.	16%	12%	+1.9
Total	100%		27%

Modelled workweek: 100% · Public evidence: 0% · Estimate: 100% · Confidence: Low

IS WORK OVER?

27%

#153 / 643

Hospital pharmacist

Task weights are our estimates based on O*NET frequency data, not time shares published by O*NET.

The time saving for each task is estimated separately.

Task	Share	AI	Points
Transcription, reconciliation and the error. Estimate No public source provides a precise figure. This is our estimate.	18%	48%	+8.6
Validate, the interaction and the one that cannot. Estimate No public source provides a precise figure. This is our estimate.	16%	40%	+6.4
Chemo, the cabinet and not mixing the batch. Estimate No public source provides a precise figure. This is our estimate.	16%	22%	+3.5
Ward, the doubt and going down to see the patient. Estimate No public source provides a precise figure. This is our estimate.	16%	28%	+4.5
The board, the expensive drug and not yielding to pressure. Estimate No public source provides a precise figure. This is our estimate.	18%	14%	+2.5
Validate the regimen, and not missing the error. Estimate No public source provides a precise figure. This is our estimate.	16%	12%	+1.9
Total	100%		27%

Modelled workweek: 100% · Public evidence: 0% · Estimate: 100% · Confidence: Low